Non-Clinical Strategies for Toxicological Evaluation of siRNA for CNS Disorders
Time: 11:00 am
day: Conference Day Two
Details:
- Exploring considerations beyond ICH landscape in meeting regulatory expectations of siRNAs
- Nonclinical evaluation and cross reactivity of siRNAs: tailoring for species selection in siRNA programs
- Key parameters for toxicology studies: exploring route of administration, dosing regimen and repeat dosing for the future of patient treatment
